Q37.0 Q37.1 Q37.2 Q37.3 Q37.4 Q37.5 Q37.8 Q37.9 Q35.1
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients, with nsCL/P or nsCPO Patients, whose four grandparents are of Vietnamese descent. written consent to participate in the study. ASA-group 1-3. Inclusion criteria control patients: Patients, without a syndrome Patients, whose four grandparents are of Vietnamese decent. written consent to participate in the study. ASA-group 1-3.
Exclusion criteria
Exclusion criteria: Exclusion criteria patient: no written consent to participate in the study. patients with a syndrome ASA-group 4-8. Exclusion criteria control: Patients, with a CL/P or CPO or signs of a CL/P or CPO Relatives of a cleft patient no written consent to participate in the study. patients with a syndrome ASA-group 4-8.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary end point of the study is to verify the identified genetic loci respectively identify further genetic loci or genes causative for non-syndromic cleft lip and palate (nsCLP) or cleft palate only (nsCPO) in a Vietnamese population. | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation of phenotyp-genotyp correlation | — |
Countries
Vietnam
Contacts
Uniklinik Köln